ViaDerma Inc (VDRM)

[2dollarbill]

VDRM PE Ratios - not destined to be penny stock

biotechs trade at 30x earnings or 5x gross sales or 15x net sales or on air if they are a r and d company, with VDRM we have sales coming this year here is the analysis broken down below

ie...from the 500,000 bottles alone will yield $62.5M gross sales
$62.5m in gross sales X 5x gross sales = 325m market cap = $1.00 - #1.50 target
OR
62.5m in gross sales @ a 50% margin = $31m in net sales X 15x net sales = 450m market cap = $2.00 + target
OR
62.5m in gross sales with a $31m in net sales which divided by outstanding stock = 0.15 cents earnings X 30x earnings (pe - price to earnings) = $4.50 + target